Myomo, Inc. (NYSE: MYO)

Myomo Inc is a wearable medical robotics company that develops and markets the MyoPro product line a myoelectric controlled upper limb brace designed to help individuals with neuromuscular disorders regain movement in their arms and hands.

It creates custom fabricated orthoses for adults and adolescents affected by conditions such as stroke brachial plexus injury spinal cord injury traumatic brain injury and cerebral palsy.

The device is prescribed by physicians and fitted by trained clinical professionals to support daily activities.

The company generates revenue primarily by selling MyoPro devices directly to patients and billing their insurance companies a process referred to as direct billing.

It also sells through orthotics and prosthetics providers the Veterans Administration and international distributors.

Revenue is recognized under two HCPCS codes L8701 and L8702 with average reimbursement amounts of approximately 34970 dollars for L8701 and 68800 dollars for L8702 effective January 2026.

The majority of devices are billed under the higher paying L8702 code.

• no_segments_reported.

Myomo holds a first mover advantage in the United States as the only commercially available device that enables neuromuscular impaired individuals to regain movement using their own muscle signals.

The company protects its technology with 35 issued patents and 14 pending applications covering the MyoPro platform through 2042.

Competitors in the broader assistive technology space include lower limb exoskeleton firms such as Lifeward Ekso Bionics and Cyberdyne as well as emerging upper limb orthosis providers like Neurolutions Vincent Systems and HKK Bionics and implantable device developers such as MicroTransponder.

Myomo’s competitive edge lies in its proprietary non invasive electromyography control system lightweight materials and custom fabrication process.

The company serves patients suffering from stroke brachial plexus injury spinal cord injury traumatic brain injury cerebral palsy and other neurological conditions.

It works with healthcare providers such as Cleveland Clinic Spaulding Rehabilitation Hospital Loma Linda University Medical Center Kennedy Krieger Institute University of Utah and numerous VA Medical Centers.

Additionally it sells to orthotics and prosthetics providers the Veterans Administration and international markets in Europe Canada and Australia.